These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32295687)

  • 81. Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership.
    Yang Y; Faustino PJ; Volpe DA; Ellison CD; Lyon RC; Yu LX
    Mol Pharm; 2007; 4(4):608-14. PubMed ID: 17637014
    [TBL] [Abstract][Full Text] [Related]  

  • 82. An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system.
    Li H; Jin HE; Shim WS; Shim CK
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1515-22. PubMed ID: 22934579
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Biopharmaceutics classification and absorption mechanisms primary study on four kinds of flavonoids].
    Li HF; Zhang D; Qu WJ; Wang HL; Liu Y; Borjigdai A; Cui J; Dong ZQ
    Zhongguo Zhong Yao Za Zhi; 2016 Apr; 41(7):1198-1203. PubMed ID: 28879731
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Computer simulations for bioequivalence trials: selection of analyte in BCS drugs with first-pass metabolism and two metabolic pathways.
    Navarro-Fontestad C; Gonzalez-Alvarez I; Fernández-Teruel C; Garcia-Arieta A; Bermejo M; Casabó VG
    Eur J Pharm Sci; 2010 Dec; 41(5):716-28. PubMed ID: 20932901
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients.
    Batchelor HK; Kendall R; Desset-Brethes S; Alex R; Ernest TB;
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):833-42. PubMed ID: 23665448
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 87. BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.
    Hosey CM; Chan R; Benet LZ
    AAPS J; 2016 Jan; 18(1):251-60. PubMed ID: 26589308
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Degrees of order: A comparison of nanocrystal and amorphous solids for poorly soluble drugs.
    Peltonen L; Strachan CJ
    Int J Pharm; 2020 Aug; 586():119492. PubMed ID: 32505579
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Novel insights into excipient effects on the biopharmaceutics of APIs from different BCS classes: Lactose in solid oral dosage forms.
    Kubbinga M; Moghani L; Langguth P
    Eur J Pharm Sci; 2014 Sep; 61():27-31. PubMed ID: 24732384
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Exploring the Relationship of Drug BCS Classification, Food Effect, and Gastric pH-Dependent Drug Interactions.
    Owens K; Argon S; Yu J; Yang X; Wu F; Lee SC; Sun WJ; Ramamoorthy A; Zhang L; Ragueneau-Majlessi I
    AAPS J; 2021 Dec; 24(1):16. PubMed ID: 34961909
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The fundamental variables of the biopharmaceutics classification system (BCS): a commentary.
    van de Waterbeemd H
    Eur J Pharm Sci; 1998 Dec; 7(1):1-3. PubMed ID: 9845781
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prediction of bioavailability of selected bisphosphonates using in silico methods towards categorization into a biopharmaceutical classification system.
    Biernacka J; Betlejewska-Kielak K; Kłosińska-Szmurło E; Pluciński FA; Mazurek AP
    Acta Pol Pharm; 2013; 70(5):877-82. PubMed ID: 24147367
    [TBL] [Abstract][Full Text] [Related]  

  • 94. BDDCS class prediction for new molecular entities.
    Broccatelli F; Cruciani G; Benet LZ; Oprea TI
    Mol Pharm; 2012 Mar; 9(3):570-80. PubMed ID: 22224483
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.
    Akers MJ
    Int J Pharm Compd; 2017; 21(1):47-56. PubMed ID: 28346198
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Transepithelial transport of biperiden hydrochloride in Caco-2 cell monolayers.
    Abalos IS; Rodríguez YI; Lozano V; Cereseto M; Mussini MV; Spinetto ME; Chiale C; Pesce G
    Environ Toxicol Pharmacol; 2012 Sep; 34(2):223-227. PubMed ID: 22554863
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Comparative Oral Drug Classification Systems: Acetazolamide, Azithromycin, Clopidogrel, and Efavirenz Case Studies.
    Mora MJ; Onnainty R; Granero GE
    Mol Pharm; 2018 Aug; 15(8):3187-3196. PubMed ID: 29927606
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pharmacokinetic simulations to explore dissolution criteria of BCS I and III biowaivers with and without MDR-1 efflux transporter.
    Kortejärvi H; Malkki J; Shawahna R; Scherrmann JM; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2014 Sep; 61():18-26. PubMed ID: 24566614
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Inorganic matrices: an answer to low drug solubility problem.
    Perioli L; Pagano C
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1559-72. PubMed ID: 23061519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.